Real-world biomarker testing and first-line treatment patterns among locally advanced, unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma patients in the US.

被引：0

作者：

Wellen, Maria

Luu, Tony

Gleason, Michelle Kathleen

Majer, Istvan Matyas

Reading, Stephanie Rummans

机构：

[1] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA USA

[2] Amgen Inc, Thousand Oaks, CA USA

[3] Amgen Europe GmbH Amgen Europe, Rotkreuz, Switzerland

来源：

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.348

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：348 / 348

页数：1